发明名称 |
HIGH AFFINITY HUMAN ANTIBODIES TO PCSK9 |
摘要 |
An human antibody or antigen-binding fragment of a human antibody that specifically binds and inhibits human proprotein convertase subtilisin/kexin type 9 (hPCSK9) characterized by the ability to reduce serum LDL cholesterol by 40-80% over a 24, 60 or 90 day period relative to predose levels, with little or no reduction in serum HDL cholesterol and/or with little or no measurable effect on liver function, as determined by ALT and AST measurements. |
申请公布号 |
KR20110094067(A) |
申请公布日期 |
2011.08.19 |
申请号 |
KR20117013676 |
申请日期 |
2009.12.15 |
申请人 |
REGENERON PHARMACEUTICALS, INC. |
发明人 |
SLEEMAN MARK W.;MARTIN JOEL H.;HUANG TAMMY T.;MACDONALD DOUGLAS |
分类号 |
C07K16/40;A61K39/395;A61P3/06;C12N15/13 |
主分类号 |
C07K16/40 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|